For those who have tried unsuccessfully to use a CPAP machine to treat sleep apnea, the Inspire implant is a breakthrough ...

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and ...

One manufacturer was forced to pay a large settlement earlier this year after it recalled a number of CPAP devices. The FDA said Zepbound’s approval for moderate to severe obstructive sleep apnea in ...

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

MADs may be effective at improving sleep apnea symptoms. However, the article suggests they are not as effective as continuous positive airway pressure (CPAP) devices, which are the standard ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

New research reveals how sleep apnea may accelerate brain aging and cognitive decline, with experts sharing crucial insights ...

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...

The FDA approved Eli Lilly's (LLY) obesity drug for the treatment of sleep apnea, sending rival ResMed (RMD) stock lower ...